US2512572A
(en)
|
|
1950-06-20 |
|
Substituted pteridines and method |
DE267495C
(de)
|
1913-09-07 |
1913-11-20 |
Max Schreiber |
Sicherheitsschloss für schmucksachen
|
CH231852A
(de)
|
1940-08-09 |
1944-04-15 |
Ig Farbenindustrie Ag |
Verfahren zur Herstellung eines Kondensationsproduktes.
|
US2581889A
(en)
|
1948-07-07 |
1952-01-08 |
Burroughs Wellcome Co |
Method of preparing pyrimidopyrazines
|
US2665275A
(en)
|
1948-12-22 |
1954-01-05 |
Allen & Hanburys Ltd |
2, 4-diamino-7, 8-disubstituted pteridines
|
GB677342A
(en)
|
1949-08-19 |
1952-08-13 |
Ici Ltd |
New pyrimidine derivatives and their use in the manufacture of pteridin derivatives
|
US2667486A
(en)
|
1951-05-24 |
1954-01-26 |
Research Corp |
2,4-diamino pteridine and derivatives
|
GB763044A
(en)
|
1952-04-18 |
1956-12-05 |
Ici Ltd |
Pteridin derivatives
|
GB785353A
(en)
|
1953-01-30 |
1957-10-30 |
Merck & Co Inc |
Substituted pteridine derivatives
|
US2740784A
(en)
|
1954-05-03 |
1956-04-03 |
Merck & Co Inc |
Process for preparing pteridines
|
US2940972A
(en)
|
1957-06-27 |
1960-06-14 |
Thomae Gmbh Dr K |
Tri-and tetra-substituted pteridine derivatives
|
US2939882A
(en)
|
1958-07-21 |
1960-06-07 |
Shell Oil Co |
Stabilized alpha, beta-unsaturated aldehydes
|
US3081230A
(en)
|
1960-09-08 |
1963-03-12 |
Smith Kline French Lab |
Diuretic and antihypertensive triaminoarylpteridines
|
US3071587A
(en)
|
1961-07-25 |
1963-01-01 |
American Cyanamid Co |
Cyanoethyl-pteridines
|
US3159628A
(en)
|
1962-05-28 |
1964-12-01 |
Smith Kline French Lab |
Pteridine-5-oxide derivatives
|
US3122546A
(en)
|
1962-12-03 |
1964-02-25 |
American Home Prod |
4, 7-diamino-2-(substituted)-n-substituted-6-pteridinecarboxamides
|
US3162635A
(en)
|
1962-08-06 |
1964-12-22 |
Searle & Co |
1, 2, 3, 4-tetrahydro-2, 4-pteridinediones and intermediates
|
NL131481C
(hu)
|
1965-04-15 |
|
|
|
DE1921308A1
(de)
|
1969-04-25 |
1971-01-07 |
Boehringer Sohn Ingelheim |
Herzwirksame Zubereitungen
|
GB1301319A
(hu)
|
1970-07-13 |
1972-12-29 |
|
|
US3859287A
(en)
|
1971-05-05 |
1975-01-07 |
Walter Wesley Parish |
Thiopteridines and process for producing same
|
US3843791A
(en)
|
1973-01-11 |
1974-10-22 |
Pfizer |
Method of killing insects with quinazolinones and quinazoline-thiones
|
DE3023369A1
(de)
|
1980-06-23 |
1982-01-14 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
AU572792B2
(en)
|
1982-09-20 |
1988-05-19 |
Wellcome Foundation Limited, The |
2-amino, 4-oxo-pteridine derivatives
|
DE3323932A1
(de)
|
1983-07-02 |
1985-01-10 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
|
DE3445298A1
(de)
|
1984-12-12 |
1986-06-12 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
|
US5149705A
(en)
|
1987-03-13 |
1992-09-22 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity
|
IT1204612B
(it)
|
1987-05-14 |
1989-03-10 |
Bioresearch Spa |
Pteridine atte alla preparazione di composizioni farmaceutiche ad attivita' antiamnesica
|
IL88507A
(en)
*
|
1987-12-03 |
1993-02-21 |
Smithkline Beckman Intercredit |
2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
|
US4943593A
(en)
|
1988-02-25 |
1990-07-24 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5021456A
(en)
|
1988-02-25 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5252608A
(en)
|
1988-02-25 |
1993-10-12 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5059714A
(en)
|
1988-02-25 |
1991-10-22 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US5182297A
(en)
|
1988-02-25 |
1993-01-26 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
US4965288A
(en)
|
1988-02-25 |
1990-10-23 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
DE3833393A1
(de)
|
1988-10-01 |
1990-04-05 |
Thomae Gmbh Dr K |
Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel
|
US5120764A
(en)
|
1988-11-01 |
1992-06-09 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
CA2015981A1
(en)
*
|
1989-05-10 |
1990-11-10 |
Thomas H. Brown |
Compounds
|
GB8910722D0
(en)
*
|
1989-05-10 |
1989-06-28 |
Smithkline Beckman Intercredit |
Compounds
|
GB8912336D0
(en)
|
1989-05-30 |
1989-07-12 |
Smithkline Beckman Intercredit |
Compounds
|
US4997854A
(en)
|
1989-08-25 |
1991-03-05 |
Trustees Of Boston University |
Anti-fibrotic agents and methods for inhibiting the activity of lysyl oxidase in-situ using adjacently positioned diamine analogue substrates
|
DE4009941A1
(de)
|
1990-03-28 |
1991-10-02 |
Thomae Gmbh Dr K |
Verwendung von pteridinen zur sensibilisierung resistenter plasmodien bei der malaria-chemotherapie und diese verbindungen enthaltende arzneimittel
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
GB9125001D0
(en)
|
1991-11-25 |
1992-01-22 |
Ici Plc |
Heterocyclic compounds
|
CA2128205C
(en)
|
1992-01-27 |
2004-03-30 |
Hiroharu Matsuoka |
Methotrexate derivatives
|
WO1993025712A1
(en)
|
1992-06-15 |
1993-12-23 |
The Regents Of The University Of California |
Screening assay for the identification of immunosuppressive drugs
|
HU214331B
(hu)
|
1992-06-17 |
1998-03-02 |
Gyógyszerkutató Intézet Kft. |
Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
AU5138493A
(en)
|
1992-09-22 |
1994-04-12 |
Cell Therapeutics, Inc. |
Novel epoxide-containing compounds
|
GB9221220D0
(en)
|
1992-10-09 |
1992-11-25 |
Sandoz Ag |
Organic componds
|
US5473070A
(en)
|
1992-11-16 |
1995-12-05 |
Cell Therapeutics, Inc. |
Substituted long chain alcohol xanthine compounds
|
WO1994014065A1
(en)
|
1992-12-14 |
1994-06-23 |
Dana-Farber Cancer Institute, Inc. |
Methods for identifying and using immunosuppressant compounds
|
IL108630A0
(en)
|
1993-02-18 |
1994-05-30 |
Fmc Corp |
Insecticidal substituted 2,4-diaminoquinazolines
|
PH31122A
(en)
|
1993-03-31 |
1998-02-23 |
Eisai Co Ltd |
Nitrogen-containing fused-heterocycle compounds.
|
US5641783A
(en)
|
1993-11-12 |
1997-06-24 |
Cell Therapeutics, Inc. |
Substituted amino alcohol compounds
|
US5670506A
(en)
|
1993-04-05 |
1997-09-23 |
Cell Therapeutics, Inc. |
Halogen, isothiocyanate or azide substituted xanthines
|
US5281603A
(en)
|
1993-04-23 |
1994-01-25 |
American Cyanamid Company |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5521190A
(en)
|
1993-05-27 |
1996-05-28 |
Fmc Corporation |
Insecticidal pterdines and 8-deazapteridines
|
US6043228A
(en)
|
1993-06-08 |
2000-03-28 |
Cancer Research Campaign Technology Limited |
O6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cells
|
AU1090795A
(en)
|
1993-11-12 |
1995-05-29 |
Cell Therapeutics, Inc. |
Method for preventing tissue injury from hypoxia
|
JPH07138238A
(ja)
|
1993-11-16 |
1995-05-30 |
Kanebo Ltd |
新規キナゾリン誘導体およびそれを有効成分とする抗腫瘍剤
|
US5525711A
(en)
|
1994-05-18 |
1996-06-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pteridine nucleotide analogs as fluorescent DNA probes
|
DE4418096A1
(de)
|
1994-05-24 |
1995-11-30 |
Cassella Ag |
Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase
|
DE4418097A1
(de)
|
1994-05-24 |
1995-11-30 |
Cassella Ag |
Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
|
US5929046A
(en)
|
1994-06-08 |
1999-07-27 |
Cancer Research Campaign Technology Limited |
Pyrimidine and purine derivatives and their use in treating tumour cells
|
US5607936A
(en)
|
1994-09-30 |
1997-03-04 |
Merck & Co., Inc. |
Substituted aryl piperazines as neurokinin antagonists
|
GB9424233D0
(en)
|
1994-11-30 |
1995-01-18 |
Zeneca Ltd |
Quinazoline derivatives
|
AU717243B2
(en)
|
1994-12-29 |
2000-03-23 |
Regents Of The University Of California, The |
Compounds for inhibition of ceramide-mediated signal transduction
|
US6323201B1
(en)
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
US5843943A
(en)
|
1994-12-29 |
1998-12-01 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
AU1301797A
(en)
|
1995-12-22 |
1997-07-17 |
Bundesrepublik Deutschland Vertreten Durch Den Bundesminister Fur Gesundheit |
Polypeptides with interleukin 16 activity, process for the preparation and use thereof
|
US5780462A
(en)
|
1995-12-27 |
1998-07-14 |
American Home Products Corporation |
Water soluble rapamycin esters
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
US5663335A
(en)
|
1996-03-01 |
1997-09-02 |
Pharmagenesis, Inc. |
Immunosuppressive compounds and methods
|
AU2666997A
(en)
|
1996-04-15 |
1997-11-07 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
In vitro prognostic test for progressors and non-progressors after hiv infection
|
IL123884A
(en)
|
1996-07-31 |
2002-04-21 |
Cmic Co Ltd |
6-formylpterin derivatives and oligomers and polymers thereof, for use as active oxygen scavengers
|
WO1998008516A1
(fr)
|
1996-08-30 |
1998-03-05 |
Suntory Limited |
Preparations servant a la prevention et au traitement de maladies provoquees par une hypofonction de l'oxyde nitrique synthase
|
EP0837063A1
(en)
|
1996-10-17 |
1998-04-22 |
Pfizer Inc. |
4-Aminoquinazoline derivatives
|
WO1999050264A1
(fr)
|
1998-03-30 |
1999-10-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de quinazoline
|
DK0956855T3
(da)
|
1998-04-24 |
2003-07-14 |
Leuven K U Res & Dev |
Immunhæmmende effekter af 8-substituerede xanthin-derivater
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
JP4315300B2
(ja)
|
1998-08-10 |
2009-08-19 |
大日本住友製薬株式会社 |
新規なキナゾリン誘導体
|
JP4342007B2
(ja)
*
|
1998-08-10 |
2009-10-14 |
大日本住友製薬株式会社 |
キナゾリン誘導体
|
US5992713A
(en)
|
1998-10-23 |
1999-11-30 |
Manabat; Gregorio S. |
Clothes hanger with slidable side attachments
|
WO2000039129A1
(en)
|
1998-12-28 |
2000-07-06 |
K.U. Leuven Research & Development |
Immunosuppressive effects of pteridine derivatives
|
US7276506B2
(en)
|
1998-12-28 |
2007-10-02 |
4 Aza Bioscience Nv |
Immunosuppressive effects of pteridine derivatives
|
EP1187615A2
(en)
|
1999-02-02 |
2002-03-20 |
K.U. Leuven Research & Development |
Immunosurpressive effects of pteridine derivatives
|
US6946465B2
(en)
|
1999-02-02 |
2005-09-20 |
4 Aza Bioscience Nv |
Immunosuppressive effects of pteridine derivatives
|
US6331547B1
(en)
|
1999-08-18 |
2001-12-18 |
American Home Products Corporation |
Water soluble SDZ RAD esters
|
YU18502A
(sh)
|
1999-09-15 |
2004-12-31 |
Warner-Lambert Company |
Pteridinoni kao inhibitori kinaza
|
DE19944767A1
(de)
|
1999-09-17 |
2001-03-29 |
Vasopharm Biotech Gmbh & Co Kg |
N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6440991B1
(en)
|
2000-10-02 |
2002-08-27 |
Wyeth |
Ethers of 7-desmethlrapamycin
|
SE0003828D0
(sv)
|
2000-10-20 |
2000-10-20 |
Astrazeneca Ab |
Novel compounds
|
DE10059864A1
(de)
|
2000-11-30 |
2002-06-13 |
Gruenenthal Gmbh |
Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate
|
WO2002088107A1
(en)
|
2001-04-26 |
2002-11-07 |
Eisai Co., Ltd. |
Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
|
EE200400042A
(et)
|
2001-06-28 |
2004-10-15 |
Essential Therapeutics, Inc. |
8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena
|
FR2828206B1
(fr)
|
2001-08-03 |
2004-09-24 |
Centre Nat Rech Scient |
Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
|
US7344702B2
(en)
|
2004-02-13 |
2008-03-18 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardial perfusion imaging
|
EP1578722A4
(en)
|
2001-10-12 |
2006-09-06 |
Irm Llc |
KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF
|
DE10202468A1
(de)
|
2002-01-23 |
2004-09-30 |
Faustus Forschungs Cie. Translational Cancer Research Gmbh |
Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
|
WO2003097615A1
(en)
|
2002-05-17 |
2003-11-27 |
Scios, Inc. |
TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-β INHIBITORS
|
CA2497971A1
(en)
|
2002-09-18 |
2004-04-01 |
Pfizer Products Inc. |
Triazole derivatives as transforming growth factor (tgf) inhibitors
|
US20050282814A1
(en)
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
KR20110050745A
(ko)
|
2002-10-03 |
2011-05-16 |
탈자진 인코포레이티드 |
혈관항상성 유지제 및 그의 사용 방법
|
US7262200B2
(en)
|
2002-10-25 |
2007-08-28 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
WO2004096286A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
US7378409B2
(en)
|
2003-08-21 |
2008-05-27 |
Bristol-Myers Squibb Company |
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
|
EP1658081B1
(en)
|
2003-08-29 |
2007-10-24 |
4 Aza Ip Nv |
Immunosuppressive effects of pteridine derivatives
|
GB2405793A
(en)
|
2003-09-12 |
2005-03-16 |
4 Aza Bioscience Nv |
Pteridine derivatives for treating TNF-alpha related disorders
|
WO2005025574A2
(en)
|
2003-09-12 |
2005-03-24 |
4 Aza Bioscience Nv |
PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES.
|
AR045944A1
(es)
|
2003-09-24 |
2005-11-16 |
Novartis Ag |
Derivados de isoquinolina 1.4-disustituidas
|
EP1673092B1
(en)
|
2003-10-17 |
2007-08-15 |
4 Aza Ip Nv |
Heterocycle-substituted pteridine derivatives and their use in therapy
|
EP1687002A4
(en)
|
2003-11-10 |
2008-07-23 |
Synta Pharmaceuticals Corp |
CONDENSED HETEROCYCLIC COMPOUNDS
|
AU2003290127A1
(en)
|
2003-12-30 |
2005-07-21 |
Vasopharm Biotech Gmbh |
4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level
|
KR101008804B1
(ko)
|
2004-01-22 |
2011-01-14 |
일라이 릴리 앤드 캄파니 |
혈관운동 증상의 치료를 위한 선택적 에스트로겐 수용체조절제
|
WO2005080377A1
(ja)
|
2004-02-20 |
2005-09-01 |
Kirin Beer Kabushiki Kaisha |
TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
|
JP2007534735A
(ja)
|
2004-04-28 |
2007-11-29 |
アロウ セラピューティクス リミテッド |
抗ウイルス剤として使用するためのモルホリニルアニリノキナゾリン誘導体
|
ES2605792T3
(es)
|
2004-05-13 |
2017-03-16 |
Icos Corporation |
Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
|
CN1583747A
(zh)
|
2004-05-26 |
2005-02-23 |
中国药科大学 |
蝶呤类一氧化氮合酶抑制剂
|
DK2258376T3
(en)
|
2004-07-27 |
2019-04-15 |
Gilead Sciences Inc |
Phosphonate analogues of HIV inhibitor compounds
|
GB0417905D0
(en)
|
2004-08-11 |
2004-09-15 |
Novartis Ag |
Organic compounds
|
WO2006035931A1
(ja)
|
2004-09-30 |
2006-04-06 |
Toshiba Solutions Corporation |
情報システムの信頼性評価システム、信頼性評価方法、信頼性評価プログラム
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
RU2382034C2
(ru)
*
|
2004-11-09 |
2010-02-20 |
Ф.Хоффманн-Ля Рош Аг |
Соединения аминохиназолинов
|
DE102004057595A1
(de)
|
2004-11-29 |
2006-06-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
|
DE102004057645A1
(de)
|
2004-11-29 |
2006-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
|
MX2007007901A
(es)
*
|
2004-12-30 |
2007-11-07 |
4 Aza Ip Nv |
Pirido-(3,2-d)pirimidinas y composiciones farmaceuticas utiles para tratamiento medico.
|
US20090264415A2
(en)
|
2004-12-30 |
2009-10-22 |
Steven De Jonghe |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
|
GB0428475D0
(en)
|
2004-12-30 |
2005-02-02 |
4 Aza Bioscience Nv |
Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
GB0503506D0
(en)
|
2005-02-21 |
2005-03-30 |
4 Aza Bioscience Nv |
Substituted pyrido(2,3-d) pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
US20090142345A1
(en)
|
2005-03-15 |
2009-06-04 |
Takeda Pharmaceutical Company Limited |
Prophylactic/therapeutic agent for cancer
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
US7418747B1
(en)
|
2005-06-13 |
2008-09-02 |
Myers Jason D |
Furniture
|
WO2006135993A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
ES2374455T3
(es)
|
2006-02-17 |
2012-02-16 |
Pfizer Limited |
Derivados de 3-deazapurinza como moduladores de tlr7.
|
ATE549338T1
(de)
|
2006-05-24 |
2012-03-15 |
Boehringer Ingelheim Int |
Substituierte pteridine, die mit einem viergliedrigen heterocyclus substituiert sind
|
EP2032585B1
(de)
|
2006-05-24 |
2014-07-23 |
Boehringer Ingelheim International GmbH |
Substituierte pteridine als therapeutika
|
US20090318456A1
(en)
|
2006-07-06 |
2009-12-24 |
Gilead Sciences, Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
DE102006033718B4
(de)
|
2006-07-20 |
2017-10-19 |
Siemens Aktiengesellschaft |
Elektrische Maschine mit schräg verlaufenden Magnetpolgrenzen
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
US9259426B2
(en)
|
2006-07-20 |
2016-02-16 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
WO2008009077A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
WO2008009079A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
Substituted pteridines useful for the treatment and prevention of viral infections
|
US8027888B2
(en)
|
2006-08-31 |
2011-09-27 |
Experian Interactive Innovation Center, Llc |
Online credit card prescreen systems and methods
|
WO2008077649A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
WO2008077650A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
PT2170888E
(pt)
|
2007-06-29 |
2015-08-21 |
Gilead Sciences Inc |
Purina derivados e sua utilização como moduladores de recetor de tipo toll 7
|
US8679485B2
(en)
|
2007-08-02 |
2014-03-25 |
Gilead Biologics, Inc. |
Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
|
CN101918365B
(zh)
|
2007-11-16 |
2013-10-09 |
吉联亚科学股份有限公司 |
人类免疫缺陷病毒复制的抑制剂
|
US8536187B2
(en)
|
2008-07-03 |
2013-09-17 |
Gilead Sciences, Inc. |
2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
|
DK2824100T3
(en)
|
2008-07-08 |
2018-04-16 |
Incyte Holdings Corp |
1,2,5-oxadiazoles as inhibitors of indolamine-2,3-dioxygenase
|
US8242106B2
(en)
|
2008-08-01 |
2012-08-14 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
WO2010019702A2
(en)
|
2008-08-12 |
2010-02-18 |
Oncomed Pharmaceuticals, Inc. |
Ddr1-binding agents and methods of use thereof
|
WO2010042489A2
(en)
|
2008-10-06 |
2010-04-15 |
Emory University |
Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
|
GB0819593D0
(en)
|
2008-10-24 |
2008-12-03 |
Ucb Pharma Sa |
Therapeutic agents
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
NZ612380A
(en)
|
2008-12-09 |
2015-01-30 |
Gilead Sciences Inc |
Modulators of toll-like receptors
|
EP2396315B1
(en)
|
2009-02-13 |
2016-08-31 |
UCB Biopharma SPRL |
Quinoline derivatives as pi3k kinase inhibitors
|
AP3622A
(en)
|
2009-05-13 |
2016-03-02 |
Gilead Sciences Inc |
Antiviral compounds
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
TWI625121B
(zh)
|
2009-07-13 |
2018-06-01 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
EP2467380B1
(en)
|
2009-08-18 |
2016-11-30 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
EP2467377B1
(en)
|
2009-08-18 |
2016-12-28 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
PL2491035T3
(pl)
|
2009-10-22 |
2018-01-31 |
Gilead Sciences Inc |
Pochodne puryny lub deazapuryny przydatne do leczenia (między innymi) infekcji wirusowych
|
WO2011057148A1
(en)
|
2009-11-05 |
2011-05-12 |
Irm Llc |
Compounds and compositions as tlr-7 activity modulators
|
WO2011072275A2
(en)
|
2009-12-11 |
2011-06-16 |
Nono, Inc. |
Agents and methods for treating ischemic and other diseases
|
SG183174A1
(en)
|
2010-02-04 |
2012-09-27 |
Gilead Biologics Inc |
Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
|
US20130085133A1
(en)
|
2010-02-08 |
2013-04-04 |
Sourthern Research Institute Office of Commercialization and Intellectual Prop. |
Anti-viral treatment and assay to screenfor anti-viral agent
|
FR2959510B1
(fr)
|
2010-04-28 |
2013-04-26 |
Centre Nat Rech Scient |
Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques
|
WO2011139637A1
(en)
|
2010-05-03 |
2011-11-10 |
Philadelphia Health & Education Corporation |
Small-molecule modulators of hiv-1 capsid stability and methods thereof
|
LT2578585T
(lt)
|
2010-05-31 |
2016-10-10 |
Ono Pharmaceutical Co., Ltd. |
Purinono darinys kaip btk kinazės inhibitorius
|
WO2012003498A1
(en)
|
2010-07-02 |
2012-01-05 |
Gilead Sciences, Inc. |
2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
|
ES2634490T3
(es)
|
2010-07-02 |
2017-09-28 |
Gilead Sciences, Inc. |
Derivados de ácido napht-2-ylacetico para tratar el sida
|
CN104530238B
(zh)
|
2010-08-27 |
2019-11-26 |
吉利德生物制剂公司 |
基质金属蛋白酶9的抗体
|
RU2603467C2
(ru)
|
2010-10-01 |
2016-11-27 |
Вентиркс Фармасьютикалз, Инк. |
Терапевтическое применение агониста tlr и комбинированная терапия
|
CN103237549A
(zh)
|
2010-10-01 |
2013-08-07 |
帆德制药股份有限公司 |
过敏性疾病的治疗方法
|
WO2012058601A1
(en)
|
2010-10-28 |
2012-05-03 |
Southern Research Institute |
Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification
|
EP2637669A4
(en)
*
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and their use
|
AR084217A1
(es)
|
2010-12-10 |
2013-05-02 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
EP2663550B1
(en)
|
2011-01-12 |
2016-12-14 |
VentiRx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
US20140088085A1
(en)
|
2011-01-12 |
2014-03-27 |
Array Biopharma, Inc |
Substituted Benzoazepines As Toll-Like Receptor Modulators
|
EP3266464A3
(en)
|
2011-02-12 |
2018-03-14 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis b infection
|
US8664230B2
(en)
|
2011-03-17 |
2014-03-04 |
The Asan Foundation |
Pyridopyrimidine derivatives and use thereof
|
LT2694484T
(lt)
|
2011-04-08 |
2018-10-10 |
Janssen Sciences Ireland Uc |
Pirimidino dariniai, skirti virusinių infekcijų gydymui
|
PE20141066A1
(es)
|
2011-04-21 |
2014-09-05 |
Gilead Sciences Inc |
Compuestos de benzotiazol
|
UA114476C2
(uk)
*
|
2011-05-18 |
2017-06-26 |
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі |
Хіназолінові похідні для лікування вірусних інфекцій та подальших захворювань
|
JP6205354B2
(ja)
|
2011-07-06 |
2017-09-27 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivの処置のための化合物
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
US8969363B2
(en)
*
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US9550835B2
(en)
|
2011-08-23 |
2017-01-24 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-DDR1 antibody having anti-tumor activity
|
GB201115529D0
(en)
|
2011-09-08 |
2011-10-26 |
Imp Innovations Ltd |
Antibodies, uses and methods
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
WO2013060881A1
(en)
*
|
2011-10-27 |
2013-05-02 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Pyridopyrimidines and their therapeutic use
|
SI2786996T1
(sl)
|
2011-11-29 |
2017-02-28 |
Ono Pharmaceutical Co., Ltd. |
Hidroklorid s purinonskimi derivati
|
WO2013090840A1
(en)
*
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors
|
US9399645B2
(en)
|
2011-12-20 |
2016-07-26 |
Boehringer Ingelheim International Gmbh |
Inhibitors of HIV replication
|
EA037918B1
(ru)
|
2011-12-21 |
2021-06-07 |
Новира Терапьютикс, Инк. |
Противовирусные агенты против гепатита в
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
ES2716811T3
(es)
|
2012-02-08 |
2019-06-17 |
Janssen Sciences Ireland Unlimited Co |
Derivados piperidinopirimidínicos para el tratamiento de infecciones víricas
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
ES2571479T3
(es)
|
2012-04-20 |
2016-05-25 |
Gilead Sciences Inc |
Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
|
US9458174B2
(en)
|
2012-05-23 |
2016-10-04 |
Stemergie Biotechnology Sa |
Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
PL2861604T3
(pl)
|
2012-06-08 |
2017-08-31 |
Gilead Sciences, Inc. |
Makrocykliczne inhibitory wirusów flaviviridae
|
WO2013185090A1
(en)
|
2012-06-08 |
2013-12-12 |
Gilead Sciences, Inc. |
Macrocyclic inhibitors of flaviviridae viruses
|
NZ703731A
(en)
|
2012-08-10 |
2018-03-23 |
Janssen Sciences Ireland Uc |
Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
|
AU2013307328B2
(en)
|
2012-08-28 |
2017-10-19 |
Janssen Sciences Ireland Uc |
Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
SG10201605291WA
(en)
|
2012-08-28 |
2016-08-30 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
PE20150776A1
(es)
|
2012-09-10 |
2015-05-21 |
Hoffmann La Roche |
6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b
|
CN104837840B
(zh)
|
2012-10-10 |
2017-08-08 |
爱尔兰詹森科学公司 |
用于治疗病毒感染及其他疾病的吡咯并[3,2‑d]嘧啶衍生物
|
EA035431B1
(ru)
|
2012-11-16 |
2020-06-15 |
Янссен Сайенсиз Айрлэнд Юси |
Гетероциклические замещенные производные 2-амино-хиназолина в качестве модуляторов tlr7 и/или tlr8 для лечения вирусных инфекций
|
SI2822954T1
(sl)
|
2012-12-21 |
2016-07-29 |
Gilead Sciences, Inc. |
Policiklične karbamoilpiridonske spojine in njihova farmacevtska uporaba
|
SG11201504982PA
(en)
|
2012-12-27 |
2015-07-30 |
Japan Tobacco Inc |
SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
|
JP6463276B2
(ja)
|
2013-02-01 |
2019-01-30 |
ウェルスタット セラピューティクス コーポレイション |
抗炎症、抗真菌、抗寄生生物及び抗癌活性を有するアミン化合物
|
AU2014220717B2
(en)
|
2013-02-21 |
2018-03-29 |
Janssen Sciences Ireland Uc |
2-aminopyrimidine derivatives for the treatment of viral infections
|
HUE034820T2
(hu)
|
2013-02-28 |
2018-02-28 |
Janssen Sciences Ireland Uc |
Szulfamoil-arilamidok és azok alkalmazása hepatitisz B kezelésére szolgáló gyógyszerként
|
US8993771B2
(en)
|
2013-03-12 |
2015-03-31 |
Novira Therapeutics, Inc. |
Hepatitis B antiviral agents
|
BR112015028873A2
(pt)
|
2013-05-17 |
2017-07-25 |
Hoffmann La Roche |
heteroaril-diidro-pirimidinas interligados na posição 6, para o tratamento e profilaxia de infecção pelo vírus da hepatite b
|
NO2865735T3
(hu)
|
2013-07-12 |
2018-07-21 |
|
|
EP3252058B1
(en)
|
2013-07-12 |
2021-01-20 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
|
MY179503A
(en)
|
2013-07-30 |
2020-11-09 |
Janssen Sciences Ireland Uc |
Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
|
BR112016028818A2
(pt)
*
|
2014-06-13 |
2017-08-22 |
Gilead Sciences Inc |
composição farmacêutica, métodos de tratamento de uma doença ou condição, de inibição da atividade de um polipeptídeo de fosfatidilinositol 3-quinase e de inibição de reações imunes excessivas ou destrutivas ou crescimento ou proliferação de células cancerosas, kit, composto, sal, isômero, ou uma mistura farmaceuticamente aceitável do mesmo, e, uso de um composto, um sal, isômero, ou uma mistura farmaceuticamente aceitável do mesmo.
|
US9670205B2
(en)
|
2015-03-04 |
2017-06-06 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
US20170071944A1
(en)
|
2015-09-15 |
2017-03-16 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
JP7171444B2
(ja)
|
2016-07-01 |
2022-11-15 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
ウイルス感染治療用のジヒドロピラノピリミジン
|